PATENT CLAIM ANALYSIS

Application Number: 15773134
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "422000"]

Abstract:
The present invention relates to novel pharmaceutical formulations. More specifically, the present invention relates to novel pharmaceutical formulations that are suitable for intraocular administration. The present invention also relates to the use of these formulations for the treatment of collagenic eye disorder such as, for example, the treatment of keratoconus.

Claim (Index 12):
A pharmaceutical composition according to  claim 11 , wherein the composition further comprises one or more carbodiimide peptide coupling reagents.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.80645
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15566034', '14240328', '13766142', '12867566', '12023977']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7278496702933991
- 35 USC 102 Novelty (BERT): 0.5157341529920102
- Combined Prediction Score: 0.7066381185632602
- Mean Citation Score: 211.996236
- Max Citation Score: 241.5023
- Similarity Product: 153.8089013883531

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test